[1]
|
Liu, C., Li, M., Wu, X., et al. (2018) Type 2 Familial Hemophagocytic Lymphohistiocytosis in Half Brothers: A Case Report. Medicine, 97, e11577. https://doi.org/10.1097/MD.0000000000011577
|
[2]
|
Imashuku, S., Morimoto, A. and Ishii, E. (2021) Virus-Triggered Secondary Hemophagocytic Lymphohistiocytosis. Acta Paediatrica, 110, 2729-2736. https://doi.org/10.1111/apa.15973
|
[3]
|
谢正德, 申昆玲. 重视儿童非肿瘤性EB病毒感染疾病的研究[J]. 首都医科大学学报, 2010, 31(2): 213-216.
|
[4]
|
Hines, M.R., Von Bahr Greenwood, T., Beutel, G., et al. (2022) Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Critical Care Medicine, 50, 860-872. https://doi.org/10.1097/CCM.0000000000005361
|
[5]
|
Otrock, Z.K. and Eby, C.S. (2015) Clinical Characteristics, Prognostic Factors, and Outcomes of Adult Patients with Hemophagocytic Lymphohistiocytosis. American Journal of Hematology, 90, 220-224.
https://doi.org/10.1002/ajh.23911
|
[6]
|
Henter, J.I., Samuelsson-Horne, A., Aricò, M., et al. (2002) Treatment of Hemophagocytic Lymphohistiocytosis with HLH-94 Immunochemotherapy and Bone Marrow Transplantation. Blood, 100, 2367-2373.
https://doi.org/10.1182/blood-2002-01-0172
|
[7]
|
丁秀云. 小儿噬血细胞综合征误诊5例分析[J]. 中国误诊学杂志, 2006, 6(10): 1911-1912.
|
[8]
|
中国医师协会血液科医师分会, 中华医学会儿科学分会血液学组, 噬血细胞综合征中国专家联盟. 中国噬血细胞综合征诊断与治疗指南(2022年版) [J]. 中华医学杂志, 2022, 102(20): 1492-1499.
|
[9]
|
Ishii, E., Ohga, S., Imashuku, S., et al. (2007) Nationwide Survey of Hemophagocytic Lymphohistio-cytosis in Japan. International Journal of Hematology, 86, 58-65. https://doi.org/10.1532/IJH97.07012
|
[10]
|
Park, H.S., Lee, J.H., Lee, J.H., et al. (2019) Fludarabine/Melphalan 100 mg/m2 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis. Trans-plantation and Cellular Therapy, 25, 1116-1121. https://doi.org/10.1016/j.bbmt.2018.11.032
|
[11]
|
Taylor, G.S., Long, H.M., Brooks, J.M., et al. (2015) The Immunology of Epstein-Barr Virus-Induced Disease. Annual Review of Immunology, 33, 787-821. https://doi.org/10.1146/annurev-immunol-032414-112326
|
[12]
|
Lindemann, T.L. and Greene, J.S. (2005) Persistent Cervical Lymphadenopathy in an Adolescent with Epstein-Barr Induced Hemophagocytic Syndrome: Manifestations of a Rare But Often Fatal Disease. International Journal of Pediatric Otorhinolaryngology, 69, 1011-1014. https://doi.org/10.1016/j.ijporl.2005.02.014
|
[13]
|
Fujiwara, S., Kimura, H., Imadome, K., et al. (2014) Current Research on Chronic Active Epstein-Barr Virus Infection in Japan. Pediatrics International, 56, 159-166. https://doi.org/10.1111/ped.12314
|
[14]
|
杨骏, 张永红, 谢正德, 等. 儿童EB病毒相关噬血淋巴组织细胞增生症26例[J]. 中国小儿血液与肿瘤杂志, 2007, 12(4): 157-160.
|
[15]
|
Henter, J.I., Horne, A., Aricó, M., et al. (2007) HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131. https://doi.org/10.1002/pbc.21039
|
[16]
|
Wang, Y., Huang, W., Hu, L., et al. (2015) Multicenter Study of Combination DEP Regimen as a Salvage Therapy for Adult Refractory Hemophagocytic Lymphohistiocytosis. Blood, 126, 2186-2192.
https://doi.org/10.1182/blood-2015-05-644914
|
[17]
|
Parikh, S.A., Kapoor, P., Letendre, L., et al. (2014) Prognostic Factors and Outcomes of Adults with Hemophagocytic Lymphohistiocytosis. Mayo Clinic Proceedings, 89, 484-492. https://doi.org/10.1016/j.mayocp.2013.12.012
|
[18]
|
Wang, J., Wang, Y., Wu, L., et al. (2016) PEG-Aspargase and DEP Regimen Combination Therapy for Refractory Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocyto-sis. Journal of Hematology & Oncology, 9, Article No. 84. https://doi.org/10.1186/s13045-016-0317-7
|
[19]
|
程雪, 徐之良. 儿童EB病毒相关性噬血细胞综合征的诊治进展[J]. 医学综述, 2018, 24(18): 3658-3663.
|
[20]
|
Li, Z., Wang, Y., Wang, J., et al. (2018) Haploidentical Hematopoietic Stem Cell Transplantation for Adult Patients with Ep-stein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis. Leukemia & Lymphoma, 59, 77-84.
https://doi.org/10.1080/10428194.2017.1330467
|
[21]
|
Ahn, J.S., Rew, S.Y., Shin, M.G., et al. (2010) Clinical Sig-nificance of Clonality and Epstein-Barr Virus Infection in Adult Patients with Hemophagocytic Lymphohistiocytosis. American Journal of Hematology, 85, 719-722.
https://doi.org/10.1002/ajh.21795
|
[22]
|
Imashuku, S. (2011) Treatment of Epstein-Barr Virus-Related Hemophago-cytic Lymphohistiocytosis (EBV-HLH); Update 2010. Journal of Pediatric Hematology/Oncology, 33, 35-39. https://doi.org/10.1097/MPH.0b013e3181f84a52
|
[23]
|
卢象对, 彭建明. EB病毒混合感染的临床分析[J]. 中国实用医药, 2019, 14(15): 69-70.
|
[24]
|
Johnson, T.S., Terrell, C.E., Millen, S.H., et al. (2014) Etoposide Selectively Ab-lates Activated T Cells to Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis. The Journal of Immunology, 192, 84-91.
https://doi.org/10.4049/jimmunol.1302282
|
[25]
|
Papageorgiou, S.G., Tsiodras, S., Siakallis, G., et al. (2016) Ep-stein Barr Virus Hemophagocytic Lymphohistiocytosis Related to Rituximab Use and Immunopathogenetic Insights. Pa-thology—Research and Practice, 212, 1194-1198.
https://doi.org/10.1016/j.prp.2016.10.003
|